Open access
Open access
Powered by Google Translator Translator

Urology

M-A: Survival for waitlisted kidney failure patients receiving transplantation vs. remaining on waiting list.

2 Mar, 2022 | 08:46h | UTC

Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis – The BMJ

 


Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Related:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 


Supportive care needs of men with prostate cancer: A systematic review of qualitative studies.

17 Feb, 2022 | 08:34h | UTC

Supportive care needs of men with prostate cancer: A systematic review update – European Journal of Cancer Care

 


Arterio-Ureteral Fistula: Systematic Review of 445 Patients.

11 Feb, 2022 | 08:13h | UTC

Arterio-Ureteral Fistula: Systematic Review of 445 Patients – Journal of Urology

 


M-A: In patients undergoing transperineal prostate biopsy, there was no significant difference in infection, fever, sepsis or readmission rates with vs. without the use of prophylactic antibiotics.

11 Feb, 2022 | 08:16h | UTC

Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies – Journal of Urology

 


Randomized trial suggests it is safe to withhold antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria or preoperative indwelling catheter.

9 Feb, 2022 | 08:41h | UTC

Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial – The Journal of Urology (link to abstract – $ for full-text)

 


AUA/SMSNA Guideline: Disorders of Ejaculation.

7 Feb, 2022 | 08:37h | UTC

Disorders of Ejaculation: An AUA/SMSNA Guideline – American Urological Association

 


Summary: 2021 CDC guidelines on sexually transmitted infections.

7 Feb, 2022 | 08:33h | UTC

2021 CDC guidelines on sexually transmitted infections – Family Medicine

Original Guideline: CDC releases new guidelines for the treatment of sexually transmitted infections.

Related: WHO Guidelines for the management of symptomatic sexually transmitted infections.

 


ESSM Position Statement: Sexual Wellbeing After Gender Affirming Surgery.

4 Feb, 2022 | 08:34h | UTC

ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery” – Sexual Medicine

 


M-A: Adverse events of immune checkpoint inhibitors therapy for urologic cancer patients in clinical trials.

3 Feb, 2022 | 08:31h | UTC

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis – European Urology

 

Commentary on Twitter

 


NCCN Guideline: Kidney Cancer.

2 Feb, 2022 | 08:30h | UTC

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Meta-analysis: Androgen deprivation therapy, in addition to radiotherapy, is associated with improved metastasis-free survival in men with localized prostate cancer.

1 Feb, 2022 | 08:24h | UTC

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Effect of ADT Use and Duration in Combination With Definitive Radiotherapy for Localized Prostate Cancer – The ASCO Post

 


M-A: The diagnostic accuracy of syndromic management for genital ulcer disease.

1 Feb, 2022 | 08:12h | UTC

The Diagnostic Accuracy of Syndromic Management for Genital Ulcer Disease: A Systematic Review and Meta-Analysis – Frontiers in Medicine

 


Perspective | Ultrahypofractionated radiotherapy for localized prostate cancer: how far can we go?

28 Jan, 2022 | 08:09h | UTC

Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go? – Clinical Oncology

 


M-A: Late kidney effects of nephron-sparing vs. radical nephrectomy for Wilms Tumor.

27 Jan, 2022 | 09:22h | UTC

Late Kidney Effects of Nephron-Sparing vs Radical Nephrectomy for Wilms Tumor: A Systematic Review and Meta-Analysis – The Journal of Urology (link to abstract – $ for full-text)

 


Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

25 Jan, 2022 | 09:28h | UTC

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

 


RCT: Single-dose 1000 mg ertapenem is non-inferior to single-dose 500 mg ceftriaxone for the treatment of gonorrhea.

25 Jan, 2022 | 09:20h | UTC

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)

 

Commentary on Twitter (thread – click for more)

 


Podcast: Erectile dysfunction pearls.

25 Jan, 2022 | 09:16h | UTC

#317 Erectile Dysfunction – The Curbsiders

 


M-A: BRCA1 and BRCA2 pathogenic variants and prostate cancer risk.

25 Jan, 2022 | 09:01h | UTC

BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis – British Journal of Cancer

 


Review: Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.

25 Jan, 2022 | 08:59h | UTC

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups – British Journal of Cancer

 


Practical Guide: Management of bladder pain syndrome.

24 Jan, 2022 | 07:52h | UTC

Management of Bladder Pain Syndrome (BPS): A Practical Guide – Advances in Urology

 


Review: Imaging of prostate cancer.

18 Jan, 2022 | 09:20h | UTC

Imaging of Prostate Cancer – Deutsches Ärzteblatt International

Related:

ASCO Guideline: Optimum Imaging Strategies for Advanced Prostate Cancer

RCT: MRI can cut overdiagnoses in prostate-cancer screening by half.

RCT: MRI-targeted biopsy safely reduces the need for biopsy in more than one-third of men at risk for prostate cancer

Meta-Analysis: Negative Predictive Value of MRI in the Detection of Clinically Significant Prostate Cancer

Study: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

Review: The Use of MRI and PET Imaging Studies for Prostate Cancer Management

Meta-Analysis: MRI plus Targeted Biopsy vs. Systematic Biopsy Alone for the Diagnosis of Prostate Cancer

Cochrane Review: MRI Pathway vs. Systematic Biopsy for Detecting Prostate Cancer

RCT: Inclusion of 18F-fluciclovine-PET/CT imaging to guide postprostatectomy salvage radiotherapy in patients with prostate cancer may improve survival free from biochemical recurrence or persistence.

Meta-analysis: Clinical Utility of MRI in the Decision-making Process Before Radical Prostatectomy

Research: Biparametric MRI (simpler, faster) May Be Used to Exclude Aggressive Disease and Avoid Unnecessary Biopsies in Men with Clinical Suspicion of Prostate Cancer

Research: MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

 


Multi-Disciplinary Guideline: Management of nephrolithiasis in pregnancy.

16 Jan, 2022 | 23:17h | UTC

Management of Nephrolithiasis in Pregnancy: Multi-Disciplinary Guidelines From an Academic Medical Center – Frontiers in Surgery

 

Commentary from the author on Twitter

 


Review: Diagnosis and treatment of sexually transmitted infections.

13 Jan, 2022 | 08:38h | UTC

Diagnosis and Treatment of Sexually Transmitted Infections: A Review – JAMA (free for a limited period)

 


RCT: Among patients with short bulbar urethral strictures, those submitted to transecting excision and primary anastomosis (tEPA) reported more penile complications compared to patients submitted to buccal mucosa grafting (BMG).

12 Jan, 2022 | 08:39h | UTC

To Transect or Not Transect: Results from the Scandinavian Urethroplasty Study, A Multicentre Randomised Study of Bulbar Urethroplasty Comparing Excision and Primary Anastomosis Versus Buccal Mucosal Grafting – European Urology

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.